Pharma - Softgel
L-ornithine-L-aspartate 150 mg, 200 mg, 300 mg, 500 mg
Therapeutic Category
Agents for liver diseases
Hyperammonemia in acute or chronic liver diseases, particularly incipient
disturbances of pre-coma, coma and hepatic encephalopathy, manifestations of pruritus, anorexia, fatigue, asthenia, urticaria
Dosage & administration
1-3 capsules, 3 times daily after meals for 1-2 weeks and then, 1 capsule, 3 times daily for 4-5 weeks
Shelf life
36 months